Consensus on the reporting and experimental design of clinical and cognitive-behavioural neurofeedback studies (CRED-nf checklist)

Tieme Janssen

doi:10.1093/brain/awaa009

Consensus on the reporting and experimental design of clinical and cognitive-behavioural neurofeedback studies (CRED-nf checklist)

Tieme Janssen

Clinical Developmental Psychology

Research output: Contribution to Journal › Article › Academic › peer-review

Abstract

Neurofeedback has begun to attract the attention and scrutiny of the scientific and medical mainstream. Here, neurofeedback researchers present a consensus-derived checklist that aims to improve the reporting and experimental design standards in the field.

Original language	English
Pages (from-to)	1674-1685
Number of pages	12
Journal	Brain
Volume	143
Issue number	6
Early online date	16 Mar 2020
DOIs	https://doi.org/10.1093/brain/awaa009
Publication status	Published - Jun 2020

Funding

U.S. has been paid for public speaking by Novartis, Medice, NeuroCare, the German Society for Biofeedback, the German Society for Psychotherapy and Psychiatry and the Akademie König und Müller. K.R. has received a grant from Takeda for another project. M.H. has a patent application for fNIRS neu-rofeedback, titled ‘Methods and systems for treating a subject using NIRS neurofeedback’ (PCT/US2017/036532, filed June 8, 2017) as well as a contract with Elsevier to edit a book titled ‘FMRI Neurofeedback’. D.B. serves as an unpaid scientific advisor for an EU-funded neurofeedback trial unrelated to the present work. B.B. was paid for public speaking by the neuroCare Group (München, Germany). M.A. is unpaid chairman of the Brainclinics Foundation, a minority shareholder in neuroCare Group (Munich, Germany), and a co-inventor on four patent applications related to EEG, neuromodulation and psychophysiology, but receives no royalties related to these patents; Research Institute Brainclinics received research funding from Brain Resource (Sydney, Australia), Urgotech (France) and neuroCare Group (München, Germany), and equipment support from Deymed, neuroConn, Brainsway and Magventure. R.T.T. has received payments to consult with neurofeedback start-up companies. R.C.D. holds patents related to rtfMRI and rtfMRI-based feedback, and is CEO and a shareholder in Omneuron, a company that has developed technology related rtfMRI-based feedback. All other authors report no competing interests. No funding was received towards this work. R.T.T. is supported by a postdoctoral fellowship from the Fonds de la recherche en santé du Québec. A.O. and M.A.L. are supported by the Center for Bioelectric Interfaces National Research University Higher School of Economics, Russian Federation Government grant, ag. No.14.641.31.0003.

Funders	Funder number
neuroCare Group
Fonds de Recherche du Québec - Santé
Takeda Pharmaceutical Company
Medical Research Council	MR/P012647/1
National Eye Institute	R01EY028746
Center for Bioelectric Interfaces National Research University Higher School of Economics, Russian Federation Government	14.641.31.0003

Access to Document

10.1093/brain/awaa009Licence: CC BY-NC

Persistent URL (handle)

Persistent link

Cite this

@article{ebd4d86e64b840508bed55d136adde5c,

title = "Consensus on the reporting and experimental design of clinical and cognitive-behavioural neurofeedback studies (CRED-nf checklist)",

abstract = "Neurofeedback has begun to attract the attention and scrutiny of the scientific and medical mainstream. Here, neurofeedback researchers present a consensus-derived checklist that aims to improve the reporting and experimental design standards in the field.",

author = "Tieme Janssen",

year = "2020",

month = jun,

doi = "10.1093/brain/awaa009",

language = "English",

volume = "143",

pages = "1674--1685",

journal = "Brain",

issn = "0006-8950",

publisher = "Oxford University Press",

number = "6",

}

TY - JOUR

T1 - Consensus on the reporting and experimental design of clinical and cognitive-behavioural neurofeedback studies (CRED-nf checklist)

AU - Janssen, Tieme

PY - 2020/6

Y1 - 2020/6

N2 - Neurofeedback has begun to attract the attention and scrutiny of the scientific and medical mainstream. Here, neurofeedback researchers present a consensus-derived checklist that aims to improve the reporting and experimental design standards in the field.

AB - Neurofeedback has begun to attract the attention and scrutiny of the scientific and medical mainstream. Here, neurofeedback researchers present a consensus-derived checklist that aims to improve the reporting and experimental design standards in the field.

UR - https://www.scopus.com/pages/publications/85086682915

UR - https://www.scopus.com/pages/publications/85086682915#tab=citedBy

U2 - 10.1093/brain/awaa009

DO - 10.1093/brain/awaa009

M3 - Article

SN - 0006-8950

VL - 143

SP - 1674

EP - 1685

JO - Brain

JF - Brain

IS - 6

ER -

Consensus on the reporting and experimental design of clinical and cognitive-behavioural neurofeedback studies (CRED-nf checklist)

Abstract

Funding

Access to Document

Persistent URL (handle)

Other files and links

Fingerprint

Cite this